RAPT RAPT Therapeutics Inc - Ordinary Shares

20.7
-0.54  -3%
Previous Close 21.24
Open 21.5
Price To Book 7.34
Market Cap 440,494,820
Shares 21,279,943
Volume 21,092
Short Ratio
Av. Daily Volume 35,008
Stock charts supplied by TradingView

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 1b data due mid-2020.
RPT193
Atopic dermatitis
Phase 2 data due 1H 2020.
FLX475 + Keytruda
Advanced Cancer
Phase 1b data due mid-2020.
RPT193
Atopic dermatitis